A detailed history of Norwood Financial Corp transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Norwood Financial Corp holds 2,415 shares of GILD stock, worth $217,808. This represents 0.26% of its overall portfolio holdings.

Number of Shares
2,415
Previous 725 233.1%
Holding current value
$217,808
Previous $58,000 203.45%
% of portfolio
0.26%
Previous 0.09%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 16, 2024

BUY
$71.58 - $87.29 $120,970 - $147,520
1,690 Added 233.1%
2,415 $176,000
Q4 2023

Jan 11, 2024

SELL
$73.27 - $83.09 $1,099 - $1,246
-15 Reduced 2.03%
725 $58,000
Q1 2022

Apr 25, 2022

SELL
$57.92 - $72.58 $1,158 - $1,451
-20 Reduced 2.63%
740 $44,000
Q4 2021

Feb 08, 2022

BUY
$64.88 - $73.64 $49,308 - $55,966
760 New
760 $55,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $113B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Norwood Financial Corp Portfolio

Follow Norwood Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norwood Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Norwood Financial Corp with notifications on news.